Azacitidine and Blast cells present - a phase IV clinical study of FDA data

Summary:

Blast cells present is reported as a side effect among people who take Azacitidine (azacitidine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Venclexta, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Blast cells present when taking Azacitidine. It is created by eHealthMe based on reports of 17,184 people who have side effects when taking Azacitidine from the FDA, and is updated regularly.

What is Azacitidine?

Azacitidine has active ingredients of azacitidine. eHealthMe is studying from 17,184 Azacitidine users. Check the latest studies of Azacitidine.

What is Blast cells present?

Blast cells present is found to be associated with 75 drugs and 113 conditions by eHealthMe. Check the latest studies of Blast cells present.

On Jul, 26, 2026

17,184 people reported to have side effects when taking Azacitidine.
Among them, 15 people (0.09%) have Blast cells present.

Could Azacitidine cause Blast cells present?

Among these 15 people:

How long have people been on Azacitidine when they have Blast cells present? *

What is the gender of people who have Blast cells present when taking Azacitidine? *

female: 46.67 %
male: 53.33 %

What is the age of people who have Blast cells present when taking Azacitidine? *

What are other drugs people take besides Azacitidine? *

What are other side effects people have besides Blast cells present? *

Pneumonia: 4 people, 26.67%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 20.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 20.00%
Thrombocytopenia (decrease of platelets in blood): 3 people, 20.00%
White Blood Cell Count Decreased: 3 people, 20.00%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 20.00%
Blood Lactate Dehydrogenase Increased: 3 people, 20.00%
Bone Marrow Failure: 2 people, 13.33%
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 2 people, 13.33%
Death: 2 people, 13.33%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 12 people, 80.00%
Pneumonia Fungal: 2 people, 13.33%
Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 2 people, 13.33%
Thrombocytopenia (decrease of platelets in blood): 1 person, 6.67%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 6.67%
Anaemia (lack of blood): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Azacitidine and have Blast cells present?

- Check whether Blast cells present is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azacitidine:

Azacitidine (17,184 reports)

Browse all side effects of Azacitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blast cells present:

Blast cells present (75 drugs)

Browse all the conditions that are associated with Blast cells present:

Blast cells present (113 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azacitidine (the active ingredients of Azacitidine) and Azacitidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.